EGFR mutation-induced alternative splicing of max contributes to growth of glycolytic tumors in brain cancer

Cell Metabolism

Volumn 17, Issue 6, 2013, Pages 1000-1008

  Babic, Ivan ^a   Anderson, Erik S ^d   Tanaka, Kazuhiro ^b   Guo, Deliang ^c   Masui, Kenta ^a   Li, Bing ^d   Zhu, Shaojun ^d   Gu, Yuchao ^a,d   Villa, Genaro R ^a,d   Akhavan, David ^d   Nathanson, David ^d   Gini, Beatrice ^a   Mareninov, Sergey ^d   Li, Rui ^d   Camacho, Carolina Espindola ^d   Kurdistani, Siavash K ^d   Eskin, Ascia ^d   Nelson, Stanley F ^d   Yong, William H ^d   Cavenee, Webster K ^a,e   Cloughesy, Timothy F ^d   Christofk, Heather R ^d   Black, Douglas L ^d   Mischel, Paul S ^a,e,f   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KOBE UNIVERSITY   (Japan)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A1 SPLICING FACTOR; MYC PROTEIN; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; BRAIN CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC CODE; GENETIC TRANSCRIPTION; GLIOBLASTOMA; GLYCOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; SURVIVAL RATE; TUMOR GROWTH; UPREGULATION;

ALTERNATIVE SPLICING; ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; GLYCOLYSIS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HETEROGRAFTS; HUMANS; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84878800044     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2013.04.013     Document Type: Article

References (30)

1. E.M. Blackwood, and R.N. Eisenman Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc Science 251 1991 1211 1217
2. Cancer Genome Atlas Research Network Comprehensive genomic characterization defines human glioblastoma genes and core pathways Nature 455 2008 1061 1068
3. H.R. Christofk, M.G. Vander Heiden, M.H. Harris, A. Ramanathan, R.E. Gerszten, R. Wei, M.D. Fleming, S.L. Schreiber, and L.C. Cantley The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth Nature 452 2008 230 233
4. H.R. Christofk, M.G. Vander Heiden, N. Wu, J.M. Asara, and L.C. Cantley Pyruvate kinase M2 is a phosphotyrosine-binding protein Nature 452 2008 181 186
5. C.V. Clower, D. Chatterjee, Z. Wang, L.C. Cantley, M.G. Vander Heiden, and A.R. Krainer The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism Proc. Natl. Acad. Sci. USA 107 2010 1894 1899
6. C.V. Dang Therapeutic targeting of Myc-reprogrammed cancer cell metabolism Cold Spring Harb. Symp. Quant. Biol. 76 2011 369 374
7. C.V. Dang MYC on the path to cancer Cell 149 2012 22 35
8. C.J. David, M. Chen, M. Assanah, P. Canoll, and J.L. Manley HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer Nature 463 2010 364 368
9. R.J. DeBerardinis, J.J. Lum, G. Hatzivassiliou, and C.B. Thompson The biology of cancer: metabolic reprogramming fuels cell growth and proliferation Cell Metab. 7 2008 11 20
10. L.W. Finley, A. Carracedo, J. Lee, A. Souza, A. Egia, J. Zhang, J. Teruya-Feldstein, P.I. Moreira, S.M. Cardoso, and C.B. Clish SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization Cancer Cell 19 2011 416 428
11. F.B. Furnari, T. Fenton, R.M. Bachoo, A. Mukasa, J.M. Stommel, A. Stegh, W.C. Hahn, K.L. Ligon, D.N. Louis, and C. Brennan Malignant astrocytic glioma: genetics, biology, and paths to treatment Genes Dev. 21 2007 2683 2710
12. B. Gan, C. Lim, G. Chu, S. Hua, Z. Ding, M. Collins, J. Hu, S. Jiang, E. Fletcher-Sananikone, and L. Zhuang FoxOs enforce a progression checkpoint to constrain mTORC1-activated renal tumorigenesis Cancer Cell 18 2010 472 484
13. D. Guo, I.J. Hildebrandt, R.M. Prins, H. Soto, M.M. Mazzotta, J. Dang, J. Czernin, J.Y. Shyy, A.D. Watson, and M. Phelps The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis Proc. Natl. Acad. Sci. USA 106 2009 12932 12937
14. D. Guo, R.M. Prins, J. Dang, D. Kuga, A. Iwanami, H. Soto, K.Y. Lin, T.T. Huang, D. Akhavan, and M.B. Hock EGFR signaling through an Akt-SREBP-1- dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy Sci. Signal. 2 2009 ra82
15. D. Guo, F. Reinitz, M. Youssef, C. Hong, D. Nathanson, D. Akhavan, D. Kuga, A.N. Amzajerdi, H. Soto, and S. Zhu An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway Cancer Discov. 1 2011 442 456
16. H.E. Hirvonen, R. Salonen, M.M. Sandberg, E. Vuorio, I. Västrik, E. Kotilainen, and H. Kalimo Differential expression of myc, max and RB1 genes in human gliomas and glioma cell lines Br. J. Cancer 69 1994 16 25
17. P.J. Hurlin, and J. Huang The MAX-interacting transcription factor network Semin. Cancer Biol. 16 2006 265 274
18. W.H. Koppenol, P.L. Bounds, and C.V. Dang Otto Warburg's contributions to current concepts of cancer metabolism Nat. Rev. Cancer 11 2011 325 337
19. A.J. Levine, and A.M. Puzio-Kuter The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes Science 330 2010 1340 1344
20. T.P. Mäkelä, P.J. Koskinen, I. Västrik, and K. Alitalo Alternative forms of Max as enhancers or suppressors of Myc-ras cotransformation Science 256 1992 373 377
21. V.K. Mootha, C.M. Lindgren, K.F. Eriksson, A. Subramanian, S. Sihag, J. Lehar, P. Puigserver, E. Carlsson, M. Ridderstråle, and E. Laurila PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes Nat. Genet. 34 2003 267 273
22. A. Mukasa, J. Wykosky, K.L. Ligon, L. Chin, W.K. Cavenee, and F. Furnari Mutant EGFR is required for maintenance of glioma growth in vivo, and its ablation leads to escape from receptor dependence Proc. Natl. Acad. Sci. USA 107 2010 2616 2621
23. I. Nakano, and H.I. Kornblum Methods for analysis of brain tumor stem cell and neural stem cell self-renewal Methods Mol. Biol. 568 2009 37 56
24. D.W. Parsons, S. Jones, X. Zhang, J.C. Lin, R.J. Leary, P. Angenendt, P. Mankoo, H. Carter, I.M. Siu, and G.L. Gallia An integrated genomic analysis of human glioblastoma multiforme Science 321 2008 1807 1812
25. S. Shen, C.C. Warzecha, R.P. Carstens, and Y. Xing MADS+: discovery of differential splicing events from Affymetrix exon junction array data Bioinformatics 26 2010 268 269
26. A. Subramanian, P. Tamayo, V.K. Mootha, S. Mukherjee, B.L. Ebert, M.A. Gillette, A. Paulovich, S.L. Pomeroy, T.R. Golub, E.S. Lander, and J.P. Mesirov Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles Proc. Natl. Acad. Sci. USA 102 2005 15545 15550
27. Q. Sun, X. Chen, J. Ma, H. Peng, F. Wang, X. Zha, Y. Wang, Y. Jing, H. Yang, and R. Chen Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth Proc. Natl. Acad. Sci. USA 108 2011 4129 4134
28. M.G. Vander Heiden, L.C. Cantley, and C.B. Thompson Understanding the Warburg effect: the metabolic requirements of cell proliferation Science 324 2009 1029 1033
29. I. Västrik, P.J. Koskinen, R. Alitalo, and T.P. Mäkelä Alternative mRNA forms and open reading frames of the max gene Oncogene 8 1993 503 507
30. R.G. Verhaak, K.A. Hoadley, E. Purdom, V. Wang, Y. Qi, M.D. Wilkerson, C.R. Miller, L. Ding, T. Golub, J.P. Mesirov Cancer Genome Atlas Research Network Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1 Cancer Cell 17 2010 98 110